Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 24Arthralgia 5Neoplasm Metastasis 3Patient Compliance 2Obesity 2Neoplasms 2Advanced Breast Cancer 2Vitamin D Deficiency 1Recurrence 1Pain 1Osteoporosis 1Nutrition Disorders 1Muscle Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Fractures, Bone 1Chronic Pain 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1Breast Cancer Organoids 1Arthritis 1

Interventions

Anastrozole 2Weights and Measures 1Leuprolide 1Interviews as Topic 1Goserelin 1Clodronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Patient Compliance × Anastrozole × Clear all
NCT00936442 2012-02-14

ARTEMIS

AstraZeneca

Completed
104 enrolled
Breast

Breast Neoplasms, Patient Compliance

NCT00555867 2011-12-23

PACT

AstraZeneca

Terminated
4,923 enrolled
Breast

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡